Drugs / Short-acting Insulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07485101 | Apr 2026 → Apr 2028 expected | — | Beijing Anzhen Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Short-acting Insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07485101 ↗ |
| Route | Intravenous | “Participants receive IV insulin infusion during cardiopulmonary bypass (CPB)” NCT07485101 ↗ |